Tofacitinib Induced Psoriasiform Lesion in a Patient With Rheumatoid Arthritis.
Kemal ErolRagıp ErtaşPublished in: Archives of rheumatology (2019)
Paradoxical psoriasis or psoriasiform lesion is an adverse effect, represented by the occurrence of a psoriasiform lesion or exacerbation of psoriasis caused by the drugs normally used for the management of psoriasis. In this article, we present the first case of a 45-year-old male patient with rheumatoid arthritis who developed psoriasiform lesions following treatment with tofacitinib, and highlight the possible pathogenetic mechanisms involved in such an occurrence.
Keyphrases
- rheumatoid arthritis
- disease activity
- risk assessment
- case report
- interstitial lung disease
- ankylosing spondylitis
- chronic obstructive pulmonary disease
- atopic dermatitis
- drug induced
- intensive care unit
- ulcerative colitis
- oxidative stress
- systemic lupus erythematosus
- acute respiratory distress syndrome
- combination therapy
- idiopathic pulmonary fibrosis
- mechanical ventilation